Paradigm Capital Management Inc/Ny
Source: SEC Form 13F · as of Mar 2026Paradigm Capital Management Inc/Ny holds 12 biotech & pharma companies tracked by BioSniper, totaling $160.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
12
Total value held
$160.5M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Globus Medical Inc. (GMED)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GMEDGlobus Medical Inc. | 822,299 | $70.8M |
| OFIXOrthofix Medical Inc. Common Stock (DE) | 3,304,899 | $37.9M |
| QDELQuidelOrtho Corp | 1,525,900 | $25.1M |
| MDXGMiMedx Group Inc | 3,410,300 | $13.5M |
| JNJJOHNSON & JOHNSON | 27,200 | $6.6M |
| ACHAccendra Health Inc. | 1,786,400 | $4.1M |
| HALOHALOZYME THERAPEUTICS, INC. | 10,000 | $646K |
| ABTABBOTT LABORATORIES | 5,400 | $554K |
| NEOGNEOGEN CORP | 52,000 | $483K |
| PFEPFIZER INC | 11,400 | $320K |
| BMYBRISTOL MYERS SQUIBB CO | 5,100 | $309K |
| TMCITreace Medical Concepts Inc. | 100,000 | $134K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.